Valeria Santini, MD, an expert in MDS from the University of Florence, discusses how your individual
genetic mutation profile provides essential information on the prognosis for your
MDS as well as specific treatments. She explains what a
complex karyotype is, its role in
myelodysplastic syndromes (
MDS) progression, and how
cytogenetic testing and the type and number of genetic mutations are important in treatment planning. The mutation profile can help doctors choose therapies targeted to the
MDS progenitor cells.
-
Share with family and friends:
Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about MDS which will help other patients, caregivers and families.